Related Experiment Video
Updated: Jul 19, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral valve surgery in non-ischemic cardiomyopathy
1Division of Cardiovascular Surgery, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
The Journal of Cardiovascular Surgery
|March 2, 2005
Summary
Dilated cardiomyopathy can cause heart failure, often worsened by mitral valve regurgitation. Surgical intervention for this condition in dilated cardiomyopathy patients shows promising short-term survival rates but requires careful management.
Area of Science:
- Cardiology
- Cardiac Surgery
- Heart Failure Research
Background:
- Dilated cardiomyopathy involves myocyte cytoskeletal weakness, leading to ventricular dilatation and heart failure.
- Functional mitral valve regurgitation affects up to 40% of heart failure patients with dilated cardiomyopathy, creating a detrimental cycle.
- Advanced valvular heart disease is a significant cause of non-ischemic cardiomyopathy.
Purpose of the Study:
- To evaluate the efficacy and outcomes of surgical management for mitral valve regurgitation in patients with non-ischemic dilated cardiomyopathy.
- To assess the risks and benefits of mitral valve repair versus replacement in this patient population.
- To compare the clinical outcomes of mitral valve surgery with cardiac transplantation.
Main Methods:
- Retrospective analysis of 43 patients with non-ischemic cardiomyopathy undergoing mitral valve repair or replacement between 1993 and 2002.
- Vigorous medical management and judicious perioperative care protocols.
- Long-term survival analysis, including 1-, 3-, and 5-year survivorship rates for mitral valve repair.
Main Results:
- Mortality for mitral valve repair or replacement was 2.3% in the studied cohort.
- Early-to-intermediate term clinical outcomes of mitral valve surgery compared favorably with cardiac transplantation.
- 1-, 3-, and 5-year survivorships after mitral valve repair were 84%, 80%, and 33%, respectively.
Conclusions:
- Surgical management of mitral valve regurgitation in dilated cardiomyopathy, when combined with optimal medical care, can be performed with acceptable operative risk.
- While early outcomes are encouraging, long-term results of mitral valve surgery in this condition are less satisfactory.
- Future research into novel therapies like cell transplantation holds potential for improving the management of dilated cardiomyopathy.
Related Concept Videos
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:27Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...